Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000899243-23-007049

Chief Accounting Officer acquired 2,310 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lyon Joseph Douglas Chief Accounting Officer 2023-03-01 Grant or award +1,155 $19.86 $22,938 1,155 D
Lyon Joseph Douglas Chief Accounting Officer 2023-03-01 Grant or award +1,155 2,310 D
Loading xslF345X03/doc4.xml…